Cytochromes P450: Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis

A.W. Munro; K.J. McLean; K.R. Marshall; A.J. Warman; G. Lewis; O. Roitel; M.J. Sutcliffe; C.A. Kemp; S. Modi; N.S. Scrutton; David Leys

doi:10.1042/bst0310625

Cytochromes P450: Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis

A.W. Munro, K.J. McLean, K.R. Marshall, A.J. Warman, G. Lewis, O. Roitel, M.J. Sutcliffe, C.A. Kemp, S. Modi, N.S. Scrutton, David Leys

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	625-630
Journal	Biochemical Society Transactions
Volume	31
Issue number	3
DOIs	https://doi.org/10.1042/bst0310625
Publication status	Published - Jun 2003
Externally published	Yes

Keywords

Chemistry

Access to Document

10.1042/bst0310625

http://dx.doi.org/10.1042/bst0310625

Cite this

@article{d1470cc47b494b3cae6dc7bec97fafad,

title = "Cytochromes P450: Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis",

keywords = "Chemistry",

author = "A.W. Munro and K.J. McLean and K.R. Marshall and A.J. Warman and G. Lewis and O. Roitel and M.J. Sutcliffe and C.A. Kemp and S. Modi and N.S. Scrutton and David Leys",

year = "2003",

month = jun,

doi = "10.1042/bst0310625",

language = "English",

volume = "31",

pages = "625--630",

journal = "Biochemical Society Transactions",

issn = "0300-5127",

publisher = "Portland Press Ltd",

number = "3",

}

TY - JOUR

T1 - Cytochromes P450

T2 - Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis

AU - Munro, A.W.

AU - McLean, K.J.

AU - Marshall, K.R.

AU - Warman, A.J.

AU - Lewis, G.

AU - Roitel, O.

AU - Sutcliffe, M.J.

AU - Kemp, C.A.

AU - Modi, S.

AU - Scrutton, N.S.

AU - Leys, David

PY - 2003/6

Y1 - 2003/6

KW - Chemistry

U2 - 10.1042/bst0310625

DO - 10.1042/bst0310625

M3 - Article

SN - 0300-5127

VL - 31

SP - 625

EP - 630

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

IS - 3

ER -